August 30, 2016 09:19 AM EDT
R&D

AM­RI plans to ax staffers, re­struc­ture af­ter com­plet­ing a $358M buy­out

John Carroll

Editor & Founder

Now that AM­RI has com­plet­ed its $358 mil­lion buy­out of the Ital­ian API man­u­fac­tur­er Eu­ti­cals, the com­pa­ny is re­struc­tur­ing, ax­ing an un­spec­i­fied num­ber of em­ploy­ees …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times